Annette Eschler
Nessuna posizione attualmente
Profilo
Annette Eschler worked as Head of Business Development at Acino International AG from 2008 to 2011.
Prior to that, she was Head of Portfolio Management at ratiopharm GmbH from 1996 to 2006 and Head of Business Development at Cimex AG from 2006 to 2008.
Eschler holds a doctorate degree from Universität Ulm.
Precedenti posizioni note di Annette Eschler
Società | Posizione | Fine |
---|---|---|
ACINO HOLDING AG | Corporate Officer/Principal | 01/04/2011 |
Cimex AG | Corporate Officer/Principal | 01/01/2008 |
Ratiopharm GmbH
Ratiopharm GmbH Pharmaceuticals: MajorHealth Technology ratiopharm GmbH engages in the production and distribution of generic drugs and pharmaceutical products. It offers pain relievers, nasal sprays, bronchial drops, as well as medicines for treating high blood pressure, cancer, pulmonary arterial hypertension, human immunodeficiency virus infection and acquired immune deficiency syndrome. The company was founded in 1973 and is headquartered in Ulm, Germany. | Corporate Officer/Principal | 01/01/2006 |
Formazione di Annette Eschler
Universität Ulm | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 3 |
---|---|
Acino International AG
Acino International AG Pharmaceuticals: MajorHealth Technology Acino International AG develops and manufactures pharmaceuticals in novel drug delivery form. The firm provides drug delivery technologies with a focus on modified release oral forms, oral dispersible forms, transdermal systems and extended release parenterals, for which it also holds patents. It offers abelcet, bactiflox, clopacin, dolonica, hydronica, neurorubine, olfen and spasfon. The company was founded in 1836 and is headquartered in Zurich, Switzerland. | Health Technology |
Ratiopharm GmbH
Ratiopharm GmbH Pharmaceuticals: MajorHealth Technology ratiopharm GmbH engages in the production and distribution of generic drugs and pharmaceutical products. It offers pain relievers, nasal sprays, bronchial drops, as well as medicines for treating high blood pressure, cancer, pulmonary arterial hypertension, human immunodeficiency virus infection and acquired immune deficiency syndrome. The company was founded in 1973 and is headquartered in Ulm, Germany. | Health Technology |
Cimex AG |
- Borsa valori
- Insiders
- Annette Eschler